Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful

EDIT stock has been on a roller coaster this year, but it may be at an appealing price for speculative buyers who believe in its CRISPR tech.

DraftKings Will Only Go Higher Once It Buys Golden Nugget Online Gaming

DraftKings' deal to buy GNOG could push the value of DKNG stock even higher than the previous estimate of $80.93 per share.

FDA Approval for Senseonics’ Glucose Monitor Could Double the Stock Price

SENS stock should follow a similar trajectory to DexCom, and if it does, it will likely explode in price following FDA approval.

All Eyes Are on Tesla’s Upcoming Q3 Earnings Release and Its Free Cash Flow

In the year ahead, TSLA stock could rise more than 60% if it reaches 33% sales gains,10% FCF margins and a 0.5% FCF yield.

Nio Stock Can Rise 37% Higher If You Consider How It Stacks Up to Tesla

Nio stock is cheap vs. Tesla given its comp values. Nio stock could rise 37% to $52 with its higher growth and lower P/S ratios vs. Tesla.